Fundz

Deverra Therapeutics is looking to raise $15,000

Jun 12, 2024•about 2 years ago

Target Amount

$15,000

Deadline

Sep 03, 2024

CIK0001822782
File Number007-00007

Issuer Information

Issuer

Deverra Therapeutics

Location

1600 fairview avenue east

seattle, washington, united states

About

Deverra Therapeutics is a clinical stage biotechnology company dedicated to the development of allogeneic, off-the-shelf cellular immunotherapies for on-demand treatment of patients with cancer and infectious diseases. The company has an exclusive license to a proprietary stem cell expansion and directed-differentiation platform from the Fred Hutchinson Cancer Research Center based on more than 20 years of federally funded research and data from 5 clinical trials. This platform can be used to generate a range of unmodified and modified immune cells to treat patients with cancer and infectious diseases.

G2 High Performer Badge

⚡ Your AI Catches Every Buying Signal

While you sleep, we analyze 1,000+ companies across all strategic moves.

Set your ICP once, then wake up to:

• Companies that just hired key executives

• Fresh funding rounds AND acquisitions

• Product launches & new partnerships

• Your top matches from ALL momentum signals

2 to 50 AI-scored leads daily, by plan

Trusted by sales, BD, and investment teams at Oracle, HubSpot, and more.

Campaign Status

Filing TypeRegulation CF (C/A)
Target Amount$15,000
Securities TypeCommon Stock

Campaign Ended

Ended 652 days ago

PlatformStartEngine Capital, LLC
View SEC Filing

Related People

Choose your plan to reveal verified contacts

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.